These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 22173839)
1. Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors. Qu W; Oya S; Lieberman BP; Ploessl K; Wang L; Wise DR; Divgi CR; Chodosh LA; Thompson CB; Kung HF J Nucl Med; 2012 Jan; 53(1):98-105. PubMed ID: 22173839 [TBL] [Abstract][Full Text] [Related]
2. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. Ploessl K; Wang L; Lieberman BP; Qu W; Kung HF J Nucl Med; 2012 Oct; 53(10):1616-24. PubMed ID: 22935578 [TBL] [Abstract][Full Text] [Related]
4. Alanine and glycine conjugates of (2S,4R)-4-[ Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446 [TBL] [Abstract][Full Text] [Related]
5. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent. Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908 [TBL] [Abstract][Full Text] [Related]
6. Preclinical study of an Li C; Liu H; Duan D; Zhou Z; Liu Z Nucl Med Biol; 2018; 64-65():34-40. PubMed ID: 30041148 [TBL] [Abstract][Full Text] [Related]
7. Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Qu W; Zha Z; Lieberman BP; Mancuso A; Stetz M; Rizzi R; Ploessl K; Wise D; Thompson C; Kung HF Acad Radiol; 2011 Aug; 18(8):932-9. PubMed ID: 21658976 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging. Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents. Wang L; Zha Z; Qu W; Qiao H; Lieberman BP; Plössl K; Kung HF Nucl Med Biol; 2012 Oct; 39(7):933-43. PubMed ID: 22542392 [TBL] [Abstract][Full Text] [Related]
11. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and biological evaluation of 5-(3-[18F]fluoropropyloxy)-L-tryptophan for tumor PET imaging. He S; Tang G; Hu K; Wang H; Wang S; Huang T; Liang X; Tang X Nucl Med Biol; 2013 Aug; 40(6):801-7. PubMed ID: 23791401 [TBL] [Abstract][Full Text] [Related]
13. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET. Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565 [TBL] [Abstract][Full Text] [Related]
15. Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivo. Wu F; Orlefors H; Bergström M; Antoni G; Omura H; Eriksson B; Watanabe Y; Långström B Anticancer Res; 2000; 20(1A):251-6. PubMed ID: 10769663 [TBL] [Abstract][Full Text] [Related]
16. S-11C-methyl-L-cysteine: a new amino acid PET tracer for cancer imaging. Deng H; Tang X; Wang H; Tang G; Wen F; Shi X; Yi C; Wu K; Meng Q J Nucl Med; 2011 Feb; 52(2):287-93. PubMed ID: 21233188 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. Wester HJ; Herz M; Weber W; Heiss P; Senekowitsch-Schmidtke R; Schwaiger M; Stöcklin G J Nucl Med; 1999 Jan; 40(1):205-12. PubMed ID: 9935078 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents. Wang L; Lieberman BP; Plössl K; Qu W; Kung HF Nucl Med Biol; 2011 Apr; 38(3):301-12. PubMed ID: 21492778 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. Qu W; Zha Z; Ploessl K; Lieberman BP; Zhu L; Wise DR; Thompson CB; Kung HF J Am Chem Soc; 2011 Feb; 133(4):1122-33. PubMed ID: 21190335 [TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model. Antunes IF; Haisma HJ; Elsinga PH; Sijbesma JW; Waarde Av; Willemsen AT; Dierckx RA; de Vries EF Nucl Med Biol; 2012 Aug; 39(6):854-63. PubMed ID: 22445742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]